2219P AGITG ASCEND: Randomised, double-blind phase II trial of certepetide (CERT) or placebo (PLA) with gemcitabine (Gem) + nab-paclitaxel (Nab) in patients with untreated metastatic pancreatic ductal adenocarcinoma (mPDAC): Updated results including planned pooled placebo analysis
Saved in:
| Title: | 2219P AGITG ASCEND: Randomised, double-blind phase II trial of certepetide (CERT) or placebo (PLA) with gemcitabine (Gem) + nab-paclitaxel (Nab) in patients with untreated metastatic pancreatic ductal adenocarcinoma (mPDAC): Updated results including planned pooled placebo analysis |
|---|---|
| Authors: | Dean, A.1 (AUTHOR), Harris, M.T.2 (AUTHOR), Sjoquist, K.3 (AUTHOR), Gebski, V.4 (AUTHOR), Karapetis, C.S.5 (AUTHOR), Lomma, C.6 (AUTHOR), Burge, M.7 (AUTHOR), Steer, C.8 (AUTHOR), Tebbutt, N.9 (AUTHOR), Lee, B.10 (AUTHOR), Jackson, C.11 (AUTHOR), Day, F.12 (AUTHOR), Padinharakam, S.13 (AUTHOR), Murray, J.14 (AUTHOR), Buck, K.K.15 (AUTHOR), Mumford, J.V.16 (AUTHOR), Siu, D.17 (AUTHOR), Lee, J.18 (AUTHOR), Gao, Y.R.19 (AUTHOR), Price, T.J.20 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1233-S1234. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189420609 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 2219P AGITG ASCEND: Randomised, double-blind phase II trial of certepetide (CERT) or placebo (PLA) with gemcitabine (Gem) + nab-paclitaxel (Nab) in patients with untreated metastatic pancreatic ductal adenocarcinoma (mPDAC): Updated results including planned pooled placebo analysis – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Dean%2C+A%2E%22">Dean, A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Harris%2C+M%2ET%2E%22">Harris, M.T.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sjoquist%2C+K%2E%22">Sjoquist, K.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gebski%2C+V%2E%22">Gebski, V.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Karapetis%2C+C%2ES%2E%22">Karapetis, C.S.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lomma%2C+C%2E%22">Lomma, C.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burge%2C+M%2E%22">Burge, M.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Steer%2C+C%2E%22">Steer, C.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tebbutt%2C+N%2E%22">Tebbutt, N.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lee%2C+B%2E%22">Lee, B.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jackson%2C+C%2E%22">Jackson, C.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Day%2C+F%2E%22">Day, F.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Padinharakam%2C+S%2E%22">Padinharakam, S.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Murray%2C+J%2E%22">Murray, J.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Buck%2C+K%2EK%2E%22">Buck, K.K.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mumford%2C+J%2EV%2E%22">Mumford, J.V.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Siu%2C+D%2E%22">Siu, D.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lee%2C+J%2E%22">Lee, J.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gao%2C+Y%2ER%2E%22">Gao, Y.R.</searchLink><relatesTo>19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Price%2C+T%2EJ%2E%22">Price, T.J.</searchLink><relatesTo>20</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS1233-S1234. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189420609 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.08.2836 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S1233 Titles: – TitleFull: 2219P AGITG ASCEND: Randomised, double-blind phase II trial of certepetide (CERT) or placebo (PLA) with gemcitabine (Gem) + nab-paclitaxel (Nab) in patients with untreated metastatic pancreatic ductal adenocarcinoma (mPDAC): Updated results including planned pooled placebo analysis Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dean, A. – PersonEntity: Name: NameFull: Harris, M.T. – PersonEntity: Name: NameFull: Sjoquist, K. – PersonEntity: Name: NameFull: Gebski, V. – PersonEntity: Name: NameFull: Karapetis, C.S. – PersonEntity: Name: NameFull: Lomma, C. – PersonEntity: Name: NameFull: Burge, M. – PersonEntity: Name: NameFull: Steer, C. – PersonEntity: Name: NameFull: Tebbutt, N. – PersonEntity: Name: NameFull: Lee, B. – PersonEntity: Name: NameFull: Jackson, C. – PersonEntity: Name: NameFull: Day, F. – PersonEntity: Name: NameFull: Padinharakam, S. – PersonEntity: Name: NameFull: Murray, J. – PersonEntity: Name: NameFull: Buck, K.K. – PersonEntity: Name: NameFull: Mumford, J.V. – PersonEntity: Name: NameFull: Siu, D. – PersonEntity: Name: NameFull: Lee, J. – PersonEntity: Name: NameFull: Gao, Y.R. – PersonEntity: Name: NameFull: Price, T.J. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement 2 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |